Related references
Note: Only part of the references are listed.DW-MRI in assessment of the hypoxic fraction, interstitial fluid pressure, and metastatic propensity of melanoma xenografts
Tord Hompland et al.
BMC CANCER (2014)
BH3-only proteins - possible proapoptotic triggers for melanoma therapy
Michael Ploetz et al.
EXPERIMENTAL DERMATOLOGY (2014)
RAF Inhibition Overcomes Resistance to TRAIL-Induced Apoptosis in Melanoma Cells
Anja Berger et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2014)
Melanoma stem cells and metastasis: mimicking hematopoietic cell trafficking?
Nayoung Lee et al.
LABORATORY INVESTIGATION (2014)
Targeting the intrinsic apoptosis pathway as a strategy for melanoma therapy
Nethia Mohana-Kumaran et al.
PIGMENT CELL & MELANOMA RESEARCH (2014)
The BH3-mimetic ABT-737 sensitizes human melanoma cells to apoptosis induced by selective BRAF inhibitors but does not reverse acquired resistance
David Wroblewski et al.
CARCINOGENESIS (2013)
Identification of dual mTORC1 and mTORC2 inhibitors in melanoma cells: Prodigiosin vs. obatoclax
M. Espona-Fiedler et al.
BIOCHEMICAL PHARMACOLOGY (2012)
Modulation of NOXA and MCL-1 as a Strategy for Sensitizing Melanoma Cells to the BH3-Mimetic ABT-737
Keryn M. Lucas et al.
CLINICAL CANCER RESEARCH (2012)
High Interstitial Fluid Pressure Is Associated with Low Tumour Penetration of Diagnostic Monoclonal Antibodies Applied for Molecular Imaging Purposes
Markus Heine et al.
PLOS ONE (2012)
PTEN Loss Confers BRAF Inhibitor Resistance to Melanoma Cells through the Suppression of BIM Expression
Kim H. T. Paraiso et al.
CANCER RESEARCH (2011)
Melanoma Biomarkers Current Status and Utility in Diagnosis, Prognosis, and Response to Therapy
Nikolas K. Haass et al.
MOLECULAR DIAGNOSIS & THERAPY (2009)
Mutant B-RAF mediates resistance to anoikis via Bad and Bim
K. Boisvert-Adamo et al.
ONCOGENE (2008)
bcl-2 expression is not associated with survival in metastatic cutaneous melanoma: A historical cohort study
Marilia B. Espindola et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2008)
Apoptosis pathways and oncolytic adenoviral vectors: promising targets and tools to overcome therapy resistance of malignant melanoma
Juergen Eberle et al.
EXPERIMENTAL DERMATOLOGY (2008)
Bim and the pro-survival bcl-2 proteins - Opposites attract, ERK repels
Katherine E. Ewings et al.
CELL CYCLE (2007)
The BH3 mimetic ABT-737 targets selective Bcl-2 proteins and efficiently induces apoptosis via Bak/Bax if Mcl-1 is neutralized
Mark F. van Delft et al.
CANCER CELL (2006)
Drug penetration in solid tumours
Andrew I. Minchinton et al.
NATURE REVIEWS CANCER (2006)
Multiple signaling pathways must be targeted to overcome drug resistance in cell lines derived from melanoma metastases
KSM Smalley et al.
MOLECULAR CANCER THERAPEUTICS (2006)
An inhibitor of Bcl-2 family proteins induces regression of solid tumours
T Oltersdorf et al.
NATURE (2005)
Apoptosis and melanoma chemoresistance
MS Soengas et al.
ONCOGENE (2003)
Share Paper
